Lung-Ji Chang, PhD
Shenzhen Geno-Immune Medical Institute
18
17
0
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+16 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (18)
Showing 10 of 18 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Zhenfeng Zhang, MD, PhD
Second Affiliated Hospital of Guangzhou Medical University
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Lei Li, M.D.
Peking Union Medical College Hospital
Shared therapeutic areas:
Stanislaw R. Burzynski, MD, PhD
Burzynski Research Institute
Shared therapeutic areas:
John D. Hainsworth, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Steven A. Rosenberg, MD, PhD
NCI - Surgery Branch
Shared therapeutic areas:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (18)
Showing 18 of 18 trials
Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections
HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV
Intervention of CAR-T Against Cervical Cancer
Engineered Immune Effectors Against Ovarian Cancer
Engineered Immune Effectors Against Cervical Cancer
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine
Combination CAR-T Cell Therapy Targeting Hematological Malignancies
Intervention of Bladder Cancer by CAR-T
Genetically Modified T Cells Against Ovarian Cancer
Intervention of Engineered Immune Effector T Cells Against Lung Cancer
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Immune Modulatory DC Vaccine Against Brain Tumor
All 18 trials loaded